| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Why Good Staff Leave and What to Do About It |
|
Digg It - Why Good Staff Leave and What to Do About It
In the last five years, employee turnover has increased by more than 25 percent. Recent studies reveal that at any one time, one third of employees plan to resign within the next two years. Successive surveys in the UK of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product employee turnover show that in retailing, hotels and restaurants, call centers and other lower paid groups turnover is often in excess of 50% per annum. Why is this happening? Since the late 1980s when organizations ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in began to downsize to reduce costs, employees got the message that everyone was expendable. When organizations cut back a little too much there were always other willing recruits to join. Other processes which historically lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. reinforced the employee/employer ‘contract’, such as training and development and succession planning, were also cut back. The security of life time employment was gone and individuals learnt that ‘making their own way’ me here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nt managing their own career first and foremost. This often meant leaving the organization to get ahead and today the most common reason people leave is to seek promotion outside the organization (53%). What to do about d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro it No single retention strategy will work across a diverse organization as each group of employees will have different retention issues. For instance, clerical workers may well need to feel they are ‘being treated wit ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc h respect’. Management may be ‘looking for opportunity for advancement’. Here are some guidelines:- 1. Manage entry into the organisation A great deal of employee turnover consists of people resigning or being di easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi smissed in the first few months of employment. Even if people stay for a year or more, they may well have decided to leave based on their first few weeks in the job. To aid retention, give prospective employees a realistic nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically job preview at the recruitment stage. Don't overstate the requirements of the role but give a true representation - warts and all. During the first few critical weeks make line managers accountable for ensuring new joiners a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ re taken through a well planned induction process. 2. Develop potential It may be stating the obvious but high potential employees need opportunities to develop and stretch. New job assignments, cross functional m ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi oves, profit and loss responsibility, and a chance to lead a new business activity all send out the message that we value your input and are prepared to invest in your future. Organizations which drive their employees into ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the ground to deliver short term targets risk damage long term. Maximise the impact of training by making sure it is relevant to the job otherwise employees will feel that they are wasting their time. Use training to expan dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod experience and support forward promotion. 3. Communicate This takes two forms. Research undertaken by the Hay Group shows that a major ‘dissatisfier’ which contributes to employee turnover is a lack of clarity ab cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin out company direction and strategy. Therefore, to increase retention, make sure all managers in the business are communicating the company mission, vision and strategy at every possible opportunity. Secondly, communication tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen is two way. Ensure wherever possible that employees have a ‘voice’ to provide feedback back to the organization via discussion forums, attitude surveys and grievance systems. Where there is no opportunity to voice dissati t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sfaction, resigning feels like the only option. 4. Reward good management Reward managers whose record at retaining people is good by including the measure in performance appraisals. Use competencies or other beha ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ioral measures to provide feedback to managers who demonstrate good listening skills, excellent coaching and who give effective feedback. Train line managers in these skills before appointing or promoting them in to leaders y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products hip roles 5. Tackle underperformance Studies have shown that many people leave their jobs because they are unhappy with their boss. Individuals respect organizations that are prepared to tackle underperformance he . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ad on. Weed out marginal performers in the management ranks. Finally, defend your organization against penetration by headhunters and others seeking to poach your staff. Keep internal email addresses confidential, train s elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ecretaries to spot calls from agencies and avoid giving them any useful information, refuse to do business with agencies who have poached your staff and enter into pacts with other employers not to poach one another’s’ staff tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Achieving a State of 'Flow' at Work WEBconference Applications For Management
|